Neuen, B. L., Catanese, B., Chang, A., Heise, M., Tricoci, P., Eckardt, K.-U., … on behalf of the POSIBIL                                                                  ESKD Investigators. (2025). Effects of Clazakizumab on Anemia and Iron Metabolism in Patients with Kidney Failure. J Am Soc Nephrol, 36(5), 923–925. https://doi.org/10.1681/ASN.0000000654

Neuen, Brendon L., Benjamin Catanese, Annamarie Chang, Mark Heise, Pierluigi Tricoci, Kai-Uwe Eckardt, G Michael Felker, et al. “Effects of Clazakizumab on Anemia and Iron Metabolism in Patients with Kidney Failure.” J Am Soc Nephrol 36, no. 5 (May 1, 2025): 923–25. https://doi.org/10.1681/ASN.0000000654.

Neuen BL, Catanese B, Chang A, Heise M, Tricoci P, Eckardt K-U, et al. Effects of Clazakizumab on Anemia and Iron Metabolism in Patients with Kidney Failure. J Am Soc Nephrol. 2025 May 1;36(5):923–5.

Neuen, Brendon L., et al. “Effects of Clazakizumab on Anemia and Iron Metabolism in Patients with Kidney Failure.” J Am Soc Nephrol, vol. 36, no. 5, May 2025, pp. 923–25. Pubmed, doi:10.1681/ASN.0000000654.

Neuen BL, Catanese B, Chang A, Heise M, Tricoci P, Eckardt K-U, Felker GM, Mahaffey KW, Wolf M, Chertow GM, on behalf of the POSIBIL                                                                  ESKD Investigators. Effects of Clazakizumab on Anemia and Iron Metabolism in Patients with Kidney Failure. J Am Soc Nephrol. 2025 May 1;36(5):923–925.